Get started
Author

Behnam Ahmadian Baghbaderani

Observed names: Ahmadian Baghbaderani, Behnam, B. Ahmadian Baghbaderani, B.A. Baghbaderani, Behnam A Baghbaderani, Behnam A. Baghbaderani, Behnam Baghbaderani, Behnam Baghbaderani Ahmadian, Behnam Ahmadian Baghbaderani
ORCID: 0000-0001-6033-625X
Observed ORCID: 0000-0001-6033-625X
OpenAlex ID: A5050540283
cGMP-Manufactured Human Induced Pluripotent Stem Cells Are Available for Pre-clinical and Clinical Applications
2015 · Behnam Ahmadian Baghbaderani, Xinghui Tian, et al. · Stem Cell Reports · 215
PDF
Detailed Characterization of Human Induced Pluripotent Stem Cells Manufactured for Therapeutic Applications
2016 · Behnam Ahmadian Baghbaderani, Adhikarla Syama, et al. · Stem Cell Reviews and Reports · 90
PDF
Spinal GABAergic Transplants Attenuate Mechanical Allodynia in a Rat Model of Neuropathic Pain
2007 · Karim Mukhida, Ivar Mendez, et al. · Stem Cells · 65
Expansion of Human Neural Precursor Cells in Large‐Scale Bioreactors for the Treatment of Neurodegenerative Disorders
2008 · Behnam A. Baghbaderani, Karim Mukhida, et al. · Biotechnology Progress · 53
PDF
Bioreactor expansion of human neural precursor cells in serum‐free media retains neurogenic potential
2009 · Behnam A. Baghbaderani, Karim Mukhida, et al. · Biotechnology and Bioengineering · 40
Human-Induced Pluripotent Stem Cells Manufactured Using a Current Good Manufacturing Practice-Compliant Process Differentiate Into Clinically Relevant Cells From Three Germ Layers
2018 · Mehdi Shafa, Fan Yang, et al. · Frontiers in Medicine · 37
PDF
Platforms for Manufacturing Allogeneic, Autologous and iPSC Cell Therapy Products: An Industry Perspective
2017 · Eytan Abraham, Behnam Baghbaderani Ahmadian, et al. · Advances in biochemical engineering, biotechnology · 37
Computational fluid dynamics modeling, a novel, and effective approach for developing scalable cell therapy manufacturing processes
2019 · Mehdi Shafa, Krishna M Panchalingam, et al. · Biotechnology and Bioengineering · 32
PDF
Survival, differentiation, and migration of bioreactor-expanded human neural precursor cells in a model of Parkinson disease in rats
2008 · Karim Mukhida, Behnam A. Baghbaderani, et al. · Neurosurgical FOCUS · 28
Long-Term Stability and Differentiation Potential of Cryopreserved cGMP-Compliant Human Induced Pluripotent Stem Cells
2019 · Mehdi Shafa, Tylor Walsh, et al. · International Journal of Molecular Sciences · 26
PDF
Characterization of human induced pluripotent stems cells: Current approaches, challenges, and future solutions
2023 · Sahana Suresh Babu, Haritha Duvvuru, et al. · Biotechnology Reports · 25
Report of the international conference on manufacturing and testing of pluripotent stem cells
2018 · Stewart Abbot, Francisca Agbanyo, et al. · Biologicals · 25
Addressing Manufacturing Challenges for Commercialization of iPSC-Based Therapies
2020 · Mehdi Dashtban, Krishna Morgan Panchalingam, et al. · Methods in molecular biology · 24
A Review of Bioreactor Protocols for Human Neural Precursor Cell Expansion in Preparation for Clinical Trials
2011 · Behnam A. Baghbaderani, Karim Mukhida, et al. · Current Stem Cell Research & Therapy · 21
Transplantation of GABAergic Cells Derived from Bioreactor-Expanded Human Neural Precursor Cells Restores Motor and Cognitive Behavioral Deficits in a Rodent Model of Huntington's Disease
2013 · Marcus C. McLeod, Nao R. Kobayashi, et al. · Cell Transplantation · 15
A multitarget basal ganglia dopaminergic and GABAergic transplantation strategy enhances behavioural recovery in parkinsonian rats
2008 · K. Mukhida, M. Hong, et al. · Brain · 15
A Newly Defined and Xeno-Free Culture Medium Supports Every-Other-Day Medium Replacement in the Generation and Long-Term Cultivation of Human Pluripotent Stem Cells
2016 · Behnam Ahmadian Baghbaderani, Xinghui Tian, et al. · PLoS ONE · 13
New bioengineering insights into human neural precursor cell expansion in culture
2011 · Behnam A. Baghbaderani, Leo A. Behie, et al. · Biotechnology Progress · 9
Two streptokinase genes are expressed with different solubility in Escherichia coli W3110
1999 · Elder Pupo, Behnam A. Baghbaderani, et al. · Biotechnology Letters · 9
Development of bioreactor protocols for stem cell‐based therapies
2021 · Krishna Panchalingam, Tony Wang, et al. · The Canadian Journal of Chemical Engineering · 7
Commercialization of Cell Therapies: A CDMO Perspective
2025 · Behnam Ahmadian Baghbaderani · Advances in experimental medicine and biology · 2
Development of Robust Cell Therapy Manufacturing Processes Largely Depends on the Choice of Cell Counting Method Considering Cell Type, Precision, and Accuracy Requirements
2022 · Dadgar Saedeh, Kuruvilla Vinitha Mary, et al. · International Journal of Stem cell Research & Therapy · 2
PDF
Key steps to industrialize your process and de-risk your pathway to commercialization
2020 · Behnam Ahmadian Baghbaderani · Cell and Gene Therapy Insights · 1
Product characterization: the evolving analytical toolkit
2016 · Behnam A Baghbaderani · Cell and Gene Therapy Insights · 1
Bioengineering Protocols for Neural Precursor Cell Expansion
2009 · Behnam A. Baghbaderani, Arindom Sen, et al. · Springer protocols handbooks/Springer protocols · 1
Works count: 34
Citation count: 794
H-index: 15
I10-index: 17
Year
Topic
Type